View More Recent Stories

Oct 28, 2024 09:25AM Organon (OGN) Completes Acquisition of Dermavant

Oct 21, 2024 05:58AM Leerink Partners Reiterates Outperform Rating on Roivant Sciences (ROIV)

Oct 16, 2024 06:15AM JPMorgan Reiterates Overweight Rating on Roivant Sciences (ROIV), 'ROIV is on the Analyst Focus List'

Sep 24, 2024 02:55PM Roivant Sciences (ROIV) 5K contracts of October 12 calls trade

Sep 19, 2024 08:11AM Goldman Sachs Reiterates Buy Rating on Roivant Sciences (ROIV)

Sep 19, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Roivant Sciences (ROIV)

Sep 18, 2024 11:56AM TD Cowen Reiterates Buy Rating on Roivant Sciences (ROIV)

Sep 18, 2024 07:30AM Organon (OGN) to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA Cream, 1%

Sep 11, 2024 08:59AM TD Cowen Reiterates Buy Rating on Roivant Sciences (ROIV)

Sep 11, 2024 06:36AM H.C. Wainwright Reiterates Buy Rating on Roivant Sciences (ROIV)

Sep 11, 2024 05:18AM Roivant Sciences (ROIV) PT Raised to $12.50 at BofA Securities

Sep 10, 2024 06:32AM Roivant Sciences (ROIV) Unveils New Pipeline Program Mosliciguat

Sep 10, 2024 06:31AM Roivant Sciences (ROIV) presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat

Sep 9, 2024 07:02AM Roivant Sciences (ROIV) Provides Update on Graves’ Disease Development Program

Sep 3, 2024 10:46AM Increasing unusual call option volume: ROIV NEXT URBN DG SBLK NCNO GPRE CAMT VUZI

Aug 26, 2024 06:19AM Increasing unusual option volume: ROIV GLNG PTEN DINO NBR NGD PRGO

Aug 19, 2024 06:49AM H.C. Wainwright Reiterates Buy Rating on Roivant Sciences (ROIV)

Aug 8, 2024 03:05PM Roivant Sciences (ROIV) spreaders active in September 10 puts, September 11 and 12 calls

Aug 8, 2024 07:45AM Roivant Sciences Ltd. (ROIV) Tops Q1 EPS by 36c

Jul 18, 2024 07:47AM Piper Sandler Reiterates Overweight Rating on Roivant Sciences (ROIV)

Jul 10, 2024 06:41AM Roivant Sciences (ROIV) PT Raised to $22 at Piper Sandler

View More Recent Stories